20
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

miR-4443 Contained Extracellular Vesicles: A Factor for Endometriosis Progression by PI3K/AKT/ACSS2 Cascade in-vitro

, , , , ORCID Icon, ORCID Icon, , , , & show all
Pages 6085-6098 | Received 01 Feb 2024, Accepted 20 May 2024, Published online: 03 Jul 2024

References

  • Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789–1799. doi:10.1016/S0140-6736(04)17403-5
  • Hickey M, Ballard K, Farquhar C. Endometriosis. BMJ. 2014;348(5):g1752. doi:10.1136/bmj.g1752
  • Škegro B, Bjedov S, Mikuš M, et al. Endometriosis, pain and mental health. Psychiatry Danub. 2021;33(Suppl 4):632–636.
  • Mikuš M, Matak L, Vujić G, et al. The short form endometriosis health profile questionnaire (EHP-5): psychometric validity assessment of a Croatian version. Arch Gynecol Obstet. 2023;307(1):87–92. doi:10.1007/s00404-022-06691-1
  • Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–412. doi:10.1093/humrep/det457
  • Rimbach S, Ulrich U, Schweppe KW. Surgical therapy of endometriosis: challenges and controversies. Geburtshilfe Frauenheilkd. 2013;73(9):918–923. doi:10.1055/s-0033-1350890
  • Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511–519. doi:10.1016/j.fertnstert.2012.06.029
  • McKinnon B, Mueller M, Montgomery G. Progesterone resistance in endometriosis: an acquired property? Trends Endocrinol Metab. 2018;29(8):535–548. doi:10.1016/j.tem.2018.05.006
  • Busacca M, Chiaffarino F, Candiani M, et al. Determinants of long-term clinically detected recurrence rates of deep, ovarian, and pelvic endometriosis. Am J Obstet Gynecol. 2006;195(2):426–432. doi:10.1016/j.ajog.2006.01.078
  • Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15(4):441–461. doi:10.1093/humupd/dmp007
  • Shimizu K, Kamada Y, Sakamoto A, Matsuda M, Nakatsuka M, Hiramatsu Y. High expression of high-mobility group box 1 in menstrual blood: implications for endometriosis. Reprod Sci. 2017;24(11):1532–1537. doi:10.1177/1933719117692042
  • Chen Y, Wang K, Xu Y, et al. Alteration of myeloid-derived suppressor cells, chronic inflammatory cytokines, and exosomal miRNA contribute to the peritoneal immune disorder of patients with endometriosis. Reprod Sci. 2019;26(8):1130–1138. doi:10.1177/1933719118808923
  • Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30(1):255–289. doi:10.1146/annurev-cellbio-101512-122326
  • Fassbender A, Burney RO, Df O, D’Hooghe T, Giudice L. Update on biomarkers for the detection of endometriosis. Biomed Res Int. 2015;2015:130854. doi:10.1155/2015/130854
  • Gupta D, Hull ML, Fraser I, et al. Endometrial biomarkers for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev. 2016;4(4):CD012165. doi:10.1002/14651858.CD012165
  • Warren LA, Shih A, Renteira SM, et al. Analysis of menstrual effluent: diagnostic potential for endometriosis. Mol Med. 2018;24(1):1. doi:10.1186/s10020-018-0009-6
  • Khalaj K, Miller JE, Lingegowda H, et al. Extracellular vesicles from endometriosis patients are characterized by a unique miRNA-lncRNA signature. JCI Insight. 2019;4(18). doi:10.1172/jci.insight.128846
  • Brennan K, Martin K, FitzGerald SP, et al. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci Rep. 2020;10(1):1039. doi:10.1038/s41598-020-57497-7
  • Zhang C, Large MJ, Duggavathi R, et al. Liver receptor homolog-1 is essential for pregnancy. Nat Med. 2013;19(8):1061–1066. doi:10.1038/nm.3192
  • Gong J, Wang J, Liu T, Hu J, Zheng J. lncRNA FEZF1AS1 contributes to cell proliferation, migration and invasion by sponging miR4443 in hepatocellular carcinoma. Mol Med Rep. 2018;18(6):5614–5620. doi:10.3892/mmr.2018.9585
  • Ebrahimi SO, Reiisi S. Downregulation of miR-4443 and miR-5195-3p in ovarian cancer tissue contributes to metastasis and tumorigenesis. Arch Gynecol Obstet. 2019;299(5):1453–1458. doi:10.1007/s00404-019-05107-x
  • Wang J, Zhang Q, Wang D, et al. Microenvironment-induced TIMP2 loss by cancer-secreted exosomal miR-4443 promotes liver metastasis of breast cancer. J Cell Physiol. 2020;235(7–8):5722–5735. doi:10.1002/jcp.29507
  • Qi Y, Zhou Y, Chen X, et al. MicroRNA-4443 causes CD4+ T cells dysfunction by targeting TNFR-associated factor 4 in Graves’ disease. Front Immunol. 2017;8:1440. doi:10.3389/fimmu.2017.01440
  • Shefler I, Salamon P, Levi-Schaffer F, Mor A, Hershko AY, Mekori YA. MicroRNA-4443 regulates mast cell activation by T cell-derived microvesicles. J Allergy Clin Immunol. 2018;141(6):2132–2141 e2134. doi:10.1016/j.jaci.2017.06.045
  • Li S, Lu G, Wang D, et al. MicroRNA-4443 regulates monocyte activation by targeting tumor necrosis factor receptor associated factor 4 in stroke-induced immunosuppression. Eur J Neurol. 2020;27(8):1625–1637. doi:10.1111/ene.14282
  • Symons LK, Miller JE, Kay VR, et al. The immunopathophysiology of endometriosis. Trends Mol Med. 2018;24(9):748–762. doi:10.1016/j.molmed.2018.07.004
  • Mikuš M, Goldštajn M, Brlečić I, et al. CTLA4-linked autoimmunity in the pathogenesis of endometriosis and related infertility: a systematic review. Int J Mol Sci. 2022;23(18):10902. doi:10.3390/ijms231810902
  • Comerford SA, Huang Z, Du X, et al. Acetate dependence of tumors. Cell. 2014;159(7):1591–1602. doi:10.1016/j.cell.2014.11.020
  • Hur H, Kim YB, Ham IH, Lee D. Loss of ACSS2 expression predicts poor prognosis in patients with gastric cancer. J Surg Oncol. 2015;112(6):585–591. doi:10.1002/jso.24043
  • Wopereis S, Radonjic M, Rubingh C, et al. Identification of prognostic and diagnostic biomarkers of glucose intolerance in ApoE3Leiden mice. Physiol Genomics. 2012;44(5):293–304. doi:10.1152/physiolgenomics.00072.2011
  • Sun L, Kong Y, Cao M, et al. Decreased expression of acetyl-CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma. Cancer Sci. 2017;108(7):1338–1346. doi:10.1111/cas.13252
  • Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 2005;4(12):988–1004. doi:10.1038/nrd1902
  • Hoxhaj G, Manning BD. The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer. 2020;20(2):74–88. doi:10.1038/s41568-019-0216-7
  • Takeuchi A, Koga K, Satake E, et al. Endometriosis triggers excessive activation of primordial follicles via PI3K-PTEN-Akt-Foxo3 pathway. J Clin Endocrinol Metab. 2019;104(11):5547–5554. doi:10.1210/jc.2019-00281
  • Madanes D, Bilotas MA, Baston JI, et al. PI3K/AKT pathway is altered in the endometriosis patient’s endometrium and presents differences according to severity stage. Gynecol Endocrinol. 2020;36(5):436–440. doi:10.1080/09513590.2019.1680627
  • Wang H, Ni C, Xiao W, Wang S. Role of lncRNA FTX in invasion, metastasis, and epithelial-mesenchymal transition of endometrial stromal cells caused by endometriosis by regulating the PI3K/Akt signaling pathway. Ann Transl Med. 2020;8(22):1504. doi:10.21037/atm-20-6810